期刊文献+

Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance:A visualization and bibliometric study

下载PDF
导出
摘要 BACKGROUND Nonalcoholic fatty liver disease(NAFLD)is a liver condition that is prevalent worldwide and associated with significant health risks and economic burdens.As it has been linked to insulin resistance(IR),this study aimed to perform a bibliometric analysis and visually represent the scientific literature on IR and NAFLD.AIM To map the research landscape to underscore critical areas of focus,influential studies,and future directions of NAFLD and IR.METHODS This study conducted a bibliometric analysis of the literature on IR and NAFLD indexed in the SciVerse Scopus database from 1999 to 2022.The search strategy used terms from the literature and medical subject headings,focusing on terms related to IR and NAFLD.VOSviewer software was used to visualize research trends,collaborations,and key thematic areas.The analysis examined publication type,annual research output,contributing countries and institutions,funding agencies,journal impact factors,citation patterns,and highly cited references.RESULTS This analysis identified 23124 documents on NAFLD,revealing a significant increase in the number of publications between 1999 and 2022.The search retrieved 715 papers on IR and NAFLD,including 573(80.14%)articles and 88(12.31%)reviews.The most productive countries were China(n=134;18.74%),the United States(n=122;17.06%),Italy(n=97;13.57%),and Japan(n=41;5.73%).The leading institutions included the Universitàdegli Studi di Torino,Italy(n=29;4.06%),and the Consiglio Nazionale delle Ricerche,Italy(n=19;2.66%).The top funding agencies were the National Institute of Diabetes and Digestive and Kidney Diseases in the United States(n=48;6.71%),and the National Natural Science Foundation of China(n=37;5.17%).The most active journals in this field were Hepatology(27 publications),the Journal of Hepatology(17 publications),and the Journal of Clinical Endocrinology and Metabolism(13 publications).The main research hotspots were“therapeutic approaches for IR and NAFLD”and“inflammatory and high-fat diet impacts on NAFLD”.CONCLUSION This is the first bibliometric analysis to examine the relationship between IR and NAFLD.In response to the escalating global health challenge of NAFLD,this research highlights an urgent need for a better understanding of this condition and for the development of intervention strategies.Policymakers need to prioritize and address the increasing prevalence of NAFLD.
出处 《World Journal of Hepatology》 2024年第6期951-965,共15页 世界肝病学杂志(英文版)(电子版)
  • 相关文献

参考文献11

二级参考文献176

  • 1Evaluating the efficacy and safety of Danning Pian in the short-term treatment of patients with non-alcoholic fatty liver disease:a multicenter clinical trial[J].Hepatobiliary & Pancreatic Diseases International,2004,3(3):375-380. 被引量:5
  • 2QiZhang,YanZhao,Deng-BenZhang,Li-JunSun.Effect of Sinai San decoction on the development of non-alcoholic steatohepatitis in rats[J].World Journal of Gastroenterology,2005,11(9):1392-1395. 被引量:6
  • 3DetlefSchuppan,Mark D.Gorrell,ThomasKlein,MichaelMark,Nezam H.Afdhal.The challenge of developing novel pharmacological therapies for non‐alcoholic steatohepatitis[J]. Liver International . 2010 (6)
  • 4张慧,胡义扬,冯琴,陈少东,许丽莉,成扬,张宁.祛湿化瘀方对游离脂肪酸诱导的HepG2细胞脂肪沉积和TNF-α分泌的抑制作用[J].中国中西医结合杂志,2007,27(12):1105-1109. 被引量:18
  • 5Veronique S. Chachay,Graeme A. Macdonald,Jennifer H. Martin,Jonathan P. Whitehead,Trisha M. O’Moore-Sullivan,Paul Lee,Michael Franklin,Kerenaftali Klein,Paul J. Taylor,Maree Ferguson,Jeff S. Coombes,Gethin P. Thomas,Gary J. Cowin,Carl M.J. Kirkpatrick,Johannes B. Prins,Ingrid J. Hickman.Resveratrol Does Not Benefit Patients with Non-alcoholic Fatty Liver Disease[J]. Clinical Gastroenterology and Hepatology . 2014
  • 6Yuefan Zhang,Shaozhan Wang,Yuanyuan Li,Zhenyu Xiao,Zhenlin Hu,Junping Zhang.Sophocarpine and matrine inhibit the production of TNF-α and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice[J].International Immunopharmacology.2008(13)
  • 7Shira Zelber-Sagi,Roni Lotan,Amir Shlomai,Muriel Webb,Gil Harrari,Assaf Buch,Dorit Nitzan Kaluski,Zamir Halpern,Ran Oren.Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up[J].Journal of Hepatology.2012(5)
  • 8Sama I. Sayin,Annika Wahlstr?m,Jenny Felin,Sirkku J?ntti,Hanns-Ulrich Marschall,Krister Bamberg,Bo Angelin,Tuulia Hy?tyl?inen,Matej Ore?i?,Fredrik B?ckhed.Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist[J].Cell Metabolism.2013(2)
  • 9Goiuri Alberdi,Víctor M. Rodríguez,M. Teresa Macarulla,Jonatan Miranda,Itziar Churruca,María P. Portillo.Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet[J].Nutrition.2013
  • 10Jian-Gao Fan,Geoffrey C. Farrell.Epidemiology of non-alcoholic fatty liver disease in China[J].Journal of Hepatology.2008(1)

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部